Jazz Pharmaceuticals

Performance

About Jazz Pharmaceuticals

Jazz Pharmaceuticals is a global biopharmaceutical company focused on identifying, developing, and commercializing medicines that address unmet medical needs. The company highlights its portfolio of medicines such as Epidiolex, Xyrem, Xywav, Defitelio, Rylaze, Vyxeos, and Zepzelca, and emphasizes commitment to improving patients’ lives across international markets. Its operations span research, development, and commercialization of therapies in areas including neurology, oncology, and rare diseases, with an emphasis on delivering meaningful clinical impact for patients worldwide.